ENTITY
Rachna T Shroff
Rachna T Shroff
PulseAugur coverage of Rachna T Shroff — every cluster mentioning Rachna T Shroff across labs, papers, and developer communities, ranked by signal.
Total · 30d
1
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
FDA approves new pancreatic cancer drug daraxonrasib after trial success
The U.S. FDA has approved daraxonrasib (Rasonque), a new targeted therapy for pancreatic ductal adenocarcinoma (PDAC) in adults whose disease has spread and failed other treatments. This marks a significant advancement …
-
Experimental pill nearly doubles survival for advanced pancreatic cancer
A new experimental pill, daraxonrasib, has shown significant promise in treating advanced pancreatic cancer by targeting a mutated protein that fuels tumor growth. In a study, patients taking the daily pill nearly doubl…